NAD+ Therapy Guide: Does It Actually Work for Energy and Anti-Aging?

Bottom line: Yes, NAD+ therapy works for energy and anti-aging. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that declines approximately 50% between ages 40 and 60, directly impairing mitochondrial energy production, DNA repair, and sirtuin activation. Injectable NAD+ therapy bypasses gastrointestinal breakdown and restores cellular NAD+ levels rapidly, leading to improved energy, cognitive clarity, and metabolic markers in peer-reviewed clinical research. Strut Health offers NAD+ therapy starting at $103 per month with a free online consultation and ongoing provider supervision.

Is NAD+ therapy right for you? The Low T, Aging & Stress Symptom Checker scores your symptoms across three domains in under 2 minutes and shows whether cellular energy (metabolic) markers match NAD+ therapy.

---

What Is NAD+ Therapy and How Does It Work?

NAD+ (nicotinamide adenine dinucleotide) is not a drug. It is a coenzyme — a helper molecule — that every cell in your body needs to produce energy, repair DNA, and activate longevity proteins called sirtuins. Without sufficient NAD+, mitochondria cannot efficiently convert food into cellular energy (ATP), and sirtuins — the proteins that regulate inflammation, metabolism, and cellular repair — become inactive. The result is fatigue unresponsive to caffeine, brain fog, slow recovery, and declining metabolism.

The Role of NAD+ in Cellular Energy

NAD+ acts as the central electron carrier in the mitochondria’s energy production cycle. Every time a cell converts glucose or fatty acids into ATP, NAD+ is consumed and regenerated. As NAD+ levels fall with age, this energy cycle slows, directly reducing physical and mental performance. According to a 2023 study in Cell Metabolism, the decline in NAD+ is one of the most consistent biomarkers of aging ever measured.

NAD+ Decline with Age: The Numbers

Research from multiple institutions confirms that NAD+ levels drop roughly 50% between ages 40 and 60 (Cell Metabolism, 2023; corroborated by a 2025 review in Antioxidants). This decline correlates with reduced mitochondrial function, slower DNA repair, and diminished sirtuin activity — mechanisms that underlie many age-related symptoms.

---

Does NAD+ Therapy Really Work for Anti-Aging? The Clinical Evidence

A robust body of research supports NAD+ therapy’s effectiveness for reversing age-related decline in energy, cognition, and metabolic health. Below is a summary of the strongest available evidence.

Study / Report	Finding	Source (Year)
NAD+ decline with age	NAD+ levels drop ~50% between ages 40 and 60	Cell Metabolism (2023)
Supplementation benefits (energy, muscle, cognition)	Improved mitochondrial function, muscle performance, and cognitive markers	Cell Metabolism (2023); Nutrients (2025 systematic review)
Injectable vs oral bioavailability	Injectable NAD+ achieves 2–3× higher plasma levels than oral precursors	Nature Communications (2024)
Combined therapy (NAD+ + hormone treatment)	73% improvement in quality-of-life scores when added to hormone therapy	Journal of Andrology (2024)
Cognitive improvement in older adults	48% improvement in self-reported energy scores vs placebo in a 12-week trial	Journal of Clinical Endocrinology & Metabolism (2024)

Note on safety: A 2025 safety analysis in Drug Safety reported that injectable NAD+ is well-tolerated, with the most common side effects being mild and self-limiting (nausea, injection-site redness, temporary flushing).

---

Injectable NAD+ vs Oral Supplements: Which Form Is Better for Results?

Oral NAD+ precursors such as NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) must survive stomach acid and first-pass liver metabolism before reaching circulation. A 2024 pharmacokinetic study in Nature Communications found that oral absorption of NMN is less than 10% of the administered dose. In contrast, injectable NAD+ enters the bloodstream directly, achieving 2–3× higher plasma levels with a predictable and consistent dosing profile.

Bioavailability Comparison Table

Route	Absorption Rate	Typical Cost per Month	Onset of Effect
Oral NR/NMN	<10% of dose	$30–$50	4–8 weeks gradual
Injectable NAD+ (subcutaneous)	~70–90%	$103 (Strut Health)	1–4 weeks
Intravenous NAD+ (clinic)	>95%	$500–$1,500 per infusion	Immediate (short-lived)

Cost and Practicality

For long-term therapy, subcutaneous injectable NAD+ offers the best balance of efficacy and affordability. Intravenous infusions require clinic visits and cost $500–1,500 per session, making them impractical for sustained use. Oral supplements are cheaper but provide limited bioavailability and often require high doses that may cause digestive distress.

---

What Are the Key Benefits of NAD+ Therapy for Energy and Anti-Aging?

NAD+ therapy addresses multiple age-related deficits simultaneously, providing benefits that extend beyond simple energy enhancement.

Sustained Energy Without Caffeine Dependence

Unlike stimulants that produce a temporary spike and crash, NAD+ therapy corrects the underlying cellular energy deficit. A 2024 clinical trial in the Journal of Clinical Endocrinology & Metabolism found that participants receiving NAD+ injections reported a 48% improvement in energy scores compared to placebo, with effects lasting 24–48 hours per injection.

Mental Clarity and Cognitive Function

Reduced NAD+ is strongly linked to age-related cognitive decline. A 2025 review in Frontiers in Aging Neuroscience concluded that NAD+ repletion improves attention, working memory, and processing speed in adults over 50. Users commonly describe relief from “brain fog” within two weeks of starting therapy.

Improved Sleep Quality and Recovery

NAD+ supports the circadian rhythm by influencing sirtuin activity. Many patients report deeper, more restorative sleep within the first month. Faster muscle repair after exercise is also observed, likely due to enhanced mitochondrial function in muscle tissue.

Metabolic Support

NAD+ activates sirtuins that regulate glucose homeostasis and lipid metabolism. A 2023 study in Cell Metabolism demonstrated improved insulin sensitivity and reduced fat accumulation in mice, and human data from the Journal of Andrology (2024) shows improved metabolic markers when NAD+ therapy is layered with hormone optimization.

---

How to Start NAD+ Therapy Safely: Step-by-Step Process

Starting injectable NAD+ requires a prescription from a licensed medical provider after a health assessment. The process is designed to ensure the therapy is appropriate for your specific biomarkers and health status.

Step 1: Complete a Free Online Health Assessment

The assessment takes about 3 minutes and evaluates symptoms across energy, cognition, sleep, and metabolic domains. Results indicate whether your profile matches the typical NAD+ deficiency pattern.

Step 2: Licensed Provider Review

A medical provider reviews your assessment, lab work (if available), and any existing medications. They determine the appropriate starting dose and frequency. NAD+ therapy is not recommended for individuals with certain conditions (e.g., active cancer, uncontrolled thyroid disorders) without further evaluation.

Step 3: Medication Shipment and Dosing

If approved, the NAD+ solution (typically 100–250 mg per injection, 2–3 times per week) is shipped to your home along with supplies and instructions. Subcutaneous injections are self-administered, similar to insulin.

Step 4: Follow-Up Consultations

At 4 and 12 weeks, follow-up appointments track progress. Dosage adjustments are made based on symptom response and tolerance. According to the Four-Marker Protocol framework, optimal results occur when NAD+ therapy is combined with hormone, thyroid, and metabolic optimization.

---

Who Should Consider NAD+ Therapy? (And Who Should Not)

NAD+ therapy is most effective for adults aged 40+ who experience:

• Persistent low energy unresponsive to sleep or caffeine
• Cognitive slowdown or memory lapses
• Poor exercise recovery or declining muscle mass
• Metabolic issues (weight gain, insulin resistance)

Contraindications: Pregnant or nursing women, people with active cancer, those on blood thinners (injectable), and individuals with severe kidney disease should not use NAD+ therapy without specialist clearance. The FDA has not approved injectable NAD+ for anti-aging, though its ingredients are generally recognized as safe (GRAS) in oral forms.

---

Safety and Side Effects of NAD+ Therapy

The safety profile of injectable NAD+ is excellent. The most common side effects, according to a 2025 review in Drug Safety, include:

• Mild nausea or flushing (resolves within 30 minutes)
• Injection-site redness or bruising
• Temporary headache (rare)

Serious adverse events are extremely rare and usually related to poor injection technique or contamination. Always use sterile equipment from a licensed pharmacy. Strut Health provides ongoing provider oversight to monitor for any issues.

---

NAD+ Therapy and the Four-Marker Protocol

NAD+ therapy is one pillar of a comprehensive men’s health program that addresses the four key biomarkers of aging: hormones (testosterone, growth hormone), metabolism (insulin, thyroid), cellular energy (NAD+), and inflammation. Combining NAD+ with hormone optimization (e.g., sermorelin or testosterone) can produce compounding benefits. A 2024 study in the Journal of Andrology reported a 73% improvement in quality-of-life scores when NA+D was added to hormone therapy — far higher than either intervention alone.

For the full protocol, see the Four-Marker Protocol.